Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Search results for:
bevacizumab
bevacizumab
Drug Name
Form
Strength
Clinic Use Only
Inpatient Restrictions
Outpatient Restrictions
Non-Formulary
Avastin
SOLUTION, INTRAVENOUS
25 mg/mL
Mvasi
SOLUTION, INTRAVENOUS
25 mg/ml
Zirabev
SOLUTION, INTRAVENOUS
25 mg/ml
VIEW MORE
antineoplastics
,
VEGF/VEGFR inhibitors
CLASS
m00020
,
m00402
High Alert Drug
:
Policy
Generic Name
Brand Name
Biosimilar (HFH preferred)
bevacizumab-bvzr
Zirabev
Biosimilar (approved alternate)
bevacizumab-awwb
Mvasi
Originator product (allowed for use by ophthalmology only)
bevacizumab
Avastin
Last updated:
Mar. 8, 2024
Biosimilar
Tier 1: Use of Biosimilars at Henry Ford Health System
Black Box Warning
GI perforation; wound healing complications
Micromedex
Clinical Pharmacology
FDA DailyMed